Related Experiment Video
Updated: Jun 5, 2026

Evaluation of Synapse Density in Hippocampal Rodent Brain Slices
Published on: October 6, 2017
The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting
Juju Zhou1, Xiaoqian Zhu1, Weihan Chen1
1Cancer Hospital of Shantou University Medical College, Shantou, China.
Abstract:
The Dickkopf (DKK) family of secreted glycoproteins, comprising DKK1-4, serves as a pivotal regulator of the Wnt signaling pathway. Acting as canonical antagonists of the Wnt/β-catenin cascade, these proteins are indispensable for essential biological processes such as cellular proliferation, differentiation, development, and tissue homeostasis. In recent years, aberrant expressions of DKK proteins has been extensively documented in multiple cancers. Simultaneously, their pathophysiological roles and clinical relevance in non-oncological diseases have garnered growing attention. Disorders such as osteoporosis and arthritis, chronic kidney disease (CKD), myocardial injury, as well as neurodegenerative and dermatological conditions, including Alzheimer's disease (AD) and alopecia, have all been linked to DKK family members. These broad associations emphasize their substantial potential as diagnostic biomarkers and as promising therapeutic targets. This review provides a systematic synthesis of recent research within the past three years on the roles of the DKK protein family in diverse non-oncological diseases, further examining their prospective applications as biomarkers and therapeutic targets while addressing related challenges, with the aim of offering novel insights into diagnosis and treatment.
Insights
Dickkopf (DKK) proteins regulate Wnt signaling and are crucial for development. Recent research highlights their roles in non-oncological diseases, suggesting potential as biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The Dickkopf (DKK) family (DKK1-4) are secreted glycoproteins.
- DKK proteins antagonize the Wnt/β-catenin signaling pathway.
- This pathway is vital for cellular proliferation, differentiation, development, and tissue homeostasis.
Purpose of the Study:
- To review recent research (past three years) on DKK protein roles in non-oncological diseases.
- To examine the potential of DKK proteins as diagnostic biomarkers.
- To explore DKK proteins as therapeutic targets for non-oncological conditions.
Main Methods:
- Systematic literature review.
- Analysis of recent research findings (past three years).
- Synthesis of data on DKK protein involvement in various diseases.
Main Results:
- DKK protein dysregulation is linked to cancers.
- DKK family members are implicated in osteoporosis, arthritis, chronic kidney disease (CKD), myocardial injury, Alzheimer's disease (AD), and alopecia.
- DKK proteins show potential as biomarkers and therapeutic targets.
Conclusions:
- DKK proteins play significant roles in diverse non-oncological diseases.
- Further research into DKK proteins could lead to novel diagnostic and therapeutic strategies.
- Addressing challenges in DKK research is key for clinical applications.
Related Concept Videos
Abnormal Proliferation
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Non-Canonical Wnt Signaling Pathways
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets
